Evidence map›Paper›PMID 33400735›Full record

ArticleOncotarget2020

Inorganic polyphosphate as an energy source in tumorigenesis.

Jerusha Boyineni, Simone T Sredni, Naira V Margaryan, Lusine Demirkhanyan, Michael Tye, Robert Johnson, Fernando Gonzalez-Nilo, Mary J C Hendrix, Evgeny Pavlov, Marcelo B Soares and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Inorganic Polyphosphate and Human Diseases.Progress in molecular and subcellular biology · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Jerusha BoyineniDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Simone T SredniDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Naira V MargaryanDepartment of Biochemistry, Robert C. Byrd Health Sciences Center and Cancer Institute, West Virginia University, Morgantown, West Virginia, USA.
Lusine DemirkhanyanDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Michael TyeDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Robert JohnsonDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Fernando Gonzalez-NiloCenter for Bioinformatics and Integrative Biology, Universidad Andres Bello, Santiago, Chile.
Mary J C HendrixDepartment of Biology, Shepherd University, Shepherdstown, West Virginia, USA.
Evgeny PavlovDepartment of Molecular Pathobiology, New York University, College of Dentistry, New York, New York, USA.
Marcelo B SoaresDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Eleonora ZakharianDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
Sergey MalchenkoDepartment of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.
University of Illinois Urbana-Champaign · USIllinois College · USNew York University · USNorthwestern University · USShepherd University · USUniversidad Andrés Bello · CLWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells have high demands for energy to maintain their exceedingly proliferative growth. However, the mechanism of energy expenditure in cancer is not well understood. We hypothesize that cancer cells might utilize energy-rich inorganic polyphosphate (polyP), as energetic reserve. PolyP is comprised of orthophosphates linked by phosphoanhydride bonds, as in ATP. Here, we show that polyP is highly abundant in several types of cancer cells, including brain tumor-initiating cells (BTICs), i.e., stem-like cells derived from a mouse brain tumor model that we have previously described. The polymer is avidly consumed during starvation of the BTICs. Depletion of ATP by inhibiting glycolysis and mitochondrial ATP-synthase (OXPHOS) further decreases the levels of polyP and alters morphology of the cells. Moreover, enzymatic hydrolysis of the polymer impairs the viability of cancer cells and significantly deprives ATP stores. These results suggest that polyP might be utilized as a source of phosphate energy in cancer. While the role of polyP as an energy source is established for bacteria, this finding is the first demonstration that polyP may play a similar role in the metabolism of cancer cells.

Indexed as

energy sourceglycolysismetabolismOXPHOSpolyphosphate

Identifiers

PMID33400735
PMCPMC7747861
OpenAlexW3113246213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.